Health Catalyst, Inc.

Health Catalyst, Inc. ( HCAT ) Q3 2026 Earnings Call November 5, 2026 5:00 PM EST Company Participants Stephanie St Clair - Senior Vice President of Finance & Investor Relations Simeon Kohl - CEO, President, Principal Executive & Operating Officer and Director Jason Alger - Chief Financial Officer Presentation Operator Welcome to the Health Catalyst Third Quarter 2026 Earnings Conference Call. [Operator Instructions] I would now like to turn the call over to Stephanie St. Clair, Senior Vice President of Finance and Investor Relations.

Health Catalyst NASDAQ: HCAT reported third-quarter revenue and adjusted EBITDA above its guidance ranges, but executives said client churn and cost pressures remain challenges as the healthcare technology company works to improve profitability.

Health Catalyst (HCAT) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to earnings of $0.06 per share a year ago.

While the top- and bottom-line numbers for Health Catalyst (HCAT) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.